Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 1994 Dec 1

PMID 7798324

Citations 423

Authors

T Katagiri

A Yamaguchi

M Komaki

E Abe

N Takahashi

T Ikeda

V Rosen

J M Wozney

T Suda

Affiliations

Soon will be listed here.

Abstract

The implantation of bone morphogenetic protein (BMP) into muscular tissues induces ectopic bone formation at the site of implantation. To investigate the mechanism underlying this process, we examined whether recombinant bone morphogenetic protein-2 (BMP-2) converts the differentiation pathway of the clonal myoblastic cell line, C2C12, into that of osteoblast lineage. Incubating the cells with 300 ng/ml of BMP-2 for 6 d almost completely inhibited the formation of the multinucleated myotubes expressing troponin T and myosin heavy chain, and induced the appearance of numerous alkaline phosphatase (ALP)-positive cells. BMP-2 dose dependently induced ALP activity, parathyroid hormone (PTH)-dependent 3',5'-cAMP production, and osteocalcin production at concentrations above 100 ng/ml. The concentration of BMP-2 required to induce these osteoblastic phenotypes was the same as that required to almost completely inhibit myotube formation. Incubating primary muscle cells with 300 ng/ml of BMP-2 for 6 d also inhibited myotube formation, whereas induced ALP activity and osteocalcin production. Incubation with 300 ng/ml of BMP-2 suppressed the expression of mRNA for muscle creatine kinase within 6 h, whereas it induced mRNA expression for ALP, PTH/PTH-related protein (PTHrP) receptors, and osteocalcin within 24-48 h. BMP-2 completely inhibited the expression of myogenin mRNA by day 3. By day 3, BMP-2 also inhibited the expression of MyoD mRNA, but it was transiently stimulated 12 h after exposure to BMP-2. Expression of Id-1 mRNA was greatly stimulated by BMP-2. When C2C12 cells pretreated with BMP-2 for 6 d were transferred to a colony assay system in the absence of BMP-2, more than 84% of the colonies generated became troponin T-positive and ALP activity disappeared. TGF-beta 1 also inhibited myotube formation in C2C12 cells, and suppressed the expression of myogenin and MyoD mRNAs without inducing that of Id-1 mRNA. However, no osteoblastic phenotype was induced by TGF-beta 1 in C2C12 cells. TGF-beta 1 potentiated the inhibitory effect of BMP-2 on myotube formation, whereas TGF-beta 1 reduced ALP activity and osteocalcin production induced by BMP-2 in C2C12 cells. These results indicate that BMP-2 specifically converts the differentiation pathway of C2C12 myoblasts into that of osteoblast lineage cells, but that the conversion is not heritable.

Citing Articles

The role of lysophosphatidylcholine acyltransferase 2 in osteoblastic differentiation of C2C12 cells.

Tabe S, Hikiji H, Hashidate-Yoshida T, Shindou H, Shimizu T, Tominaga K FEBS Open Bio. 2024; 14(9):1490-1502.

PMID: 39075841 PMC: 11492341. DOI: 10.1002/2211-5463.13845.

DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.

Rich J, Bennaroch M, Notel L, Patalakh P, Alberola J, Issa F EMBO Mol Med. 2024; 16(8):1840-1885.

PMID: 39009887 PMC: 11319797. DOI: 10.1038/s44321-024-00097-z.

Molecular mechanism of BMP signal control by Twisted gastrulation.

Malinauskas T, Moore G, Rudolf A, Eggington H, Belnoue-Davis H, El Omari K Nat Commun. 2024; 15(1):4976.

PMID: 38862520 PMC: 11167000. DOI: 10.1038/s41467-024-49065-8.

Regulating the bioactivity of non-glycosylated recombinant human bone morphogenetic protein-2 to enhance bone regeneration.

Yu Y, Chen R, Chen X, Wang J, Liu C Bioact Mater. 2024; 38:169-180.

PMID: 38711759 PMC: 11070760. DOI: 10.1016/j.bioactmat.2024.04.018.

Royal Jelly Enhances the Ability of Myoblast C2C12 Cells to Differentiate into Multilineage Cells.

Ito T, Rojasawasthien T, Takeuchi S, Okamoto H, Okumura N, Shirakawa T Molecules. 2024; 29(7).

PMID: 38611729 PMC: 11013243. DOI: 10.3390/molecules29071449.

References

Abe H, Komiya T, Obinata T . Expression of multiple troponin T variants in neonatal chicken breast muscle. Dev Biol. 1986; 118(1):42-51. DOI: 10.1016/0012-1606(86)90071-0. View

Massague J, Cheifetz S, Endo T, Nadal-Ginard B . Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci U S A. 1986; 83(21):8206-10. PMC: 386896. DOI: 10.1073/pnas.83.21.8206. View

Noda M, Rodan G . Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem Biophys Res Commun. 1986; 140(1):56-65. DOI: 10.1016/0006-291x(86)91057-0. View

FLORINI J, Roberts A, Ewton D, Falen S, Flanders K, Sporn M . Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J Biol Chem. 1986; 261(35):16509-13. View

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

Clegg C, Linkhart T, Olwin B, Hauschka S . Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol. 1987; 105(2):949-56. PMC: 2114757. DOI: 10.1083/jcb.105.2.949. View

Spizz G, Hu J, Olson E . Inhibition of myogenic differentiation by fibroblast growth factor or type beta transforming growth factor does not require persistent c-myc expression. Dev Biol. 1987; 123(2):500-7. DOI: 10.1016/0012-1606(87)90408-8. View

Sampath T, Muthukumaran N, Reddi A . Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci U S A. 1987; 84(20):7109-13. PMC: 299239. DOI: 10.1073/pnas.84.20.7109. View

Davis R, Weintraub H, Lassar A . Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987; 51(6):987-1000. DOI: 10.1016/0092-8674(87)90585-x. View

10.

Rosen D, Stempien S, Thompson A, Seyedin S . Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro. J Cell Physiol. 1988; 134(3):337-46. DOI: 10.1002/jcp.1041340304. View

11.

Elford P, Guenther H, Felix R, Cecchini M, Fleisch H . Transforming growth factor-beta reduces the phenotypic expression of osteoblastic MC3T3-E1 cells in monolayer culture. Bone. 1987; 8(4):259-62. DOI: 10.1016/8756-3282(87)90174-8. View

12.

Grigoriadis A, Heersche J, Aubin J . Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J Cell Biol. 1988; 106(6):2139-51. PMC: 2115137. DOI: 10.1083/jcb.106.6.2139. View

13.

Noda M, Yoon K, Thiede M, Buenaga R, Weiss M, Henthorn P . cDNA cloning of alkaline phosphatase from rat osteosarcoma (ROS 17/2.8) cells. J Bone Miner Res. 1987; 2(2):161-4. DOI: 10.1002/jbmr.5650020212. View

14.

Tapscott S, Davis R, Thayer M, Cheng P, Weintraub H, Lassar A . MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science. 1988; 242(4877):405-11. DOI: 10.1126/science.3175662. View

15.

Wang E, Rosen V, Cordes P, Hewick R, Kriz M, Luxenberg D . Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A. 1988; 85(24):9484-8. PMC: 282777. DOI: 10.1073/pnas.85.24.9484. View

16.

Wozney J, Rosen V, Celeste A, Mitsock L, Whitters M, Kriz R . Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242(4885):1528-34. DOI: 10.1126/science.3201241. View

17.

Noda M . Transcriptional regulation of osteocalcin production by transforming growth factor-beta in rat osteoblast-like cells. Endocrinology. 1989; 124(2):612-7. DOI: 10.1210/endo-124-2-612. View

18.

Wright W, Sassoon D, Lin V . Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell. 1989; 56(4):607-17. DOI: 10.1016/0092-8674(89)90583-7. View

19.

Wright W . Muscle basic helix-loop-helix proteins and the regulation of myogenesis. Curr Opin Genet Dev. 1992; 2(2):243-8. DOI: 10.1016/s0959-437x(05)80280-1. View

20.

Jen Y, Weintraub H, Benezra R . Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev. 1992; 6(8):1466-79. DOI: 10.1101/gad.6.8.1466. View